Century Therapeutics, Inc. Contracts & Agreements
69 Contracts & Agreements
- Business Finance (20 contracts)
- Business Operations (9)
- Human Resources (19)
- Intellectual Property (11)
- Mergers & Acquisitions (1)
- Uncategorized (9)
- Form of Performance-Based Restricted Stock Unit Grant Notice and Award Agreement, under the Company's 2021 Equity Incentive Plan (Filed With SEC on November 5, 2024)
- Executive Employment Agreement, dated September 13, 2024, by and between the Company and Chad Cowan (Filed With SEC on November 5, 2024)
- Executive Employment Agreement, dated September 20, 2024, by and between the Company and Morgan Conn (Filed With SEC on November 5, 2024)
- Registration Rights Agreement, dated April 11, 2024, by and among the Company and the other parties thereto (Filed With SEC on April 11, 2024)
- Securities Purchase Agreement, dated April 11, 2024, by and among the Company and the other parties thereto (Filed With SEC on April 11, 2024)
- Agreement and Plan of Merger, dated April 11, 2024, by and among the Company and the other parties thereto (Filed With SEC on April 11, 2024)
- Executive Employment Agreement, by and between the Registrant and Brent Pfeiffenberger, Pharm.D., MBA, dated November 7, 2023 (Filed With SEC on March 14, 2024)
- License Agreement by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 22, 2023 (Filed With SEC on March 14, 2024)
- Second Amendment to License Agreement (Differentiation), by and between the Company and FUJIFILM Cellular Dynamics Inc., dated September 22, 2023 (Filed With SEC on November 9, 2023)
- Amendment No. 5 to Master Collaboration Agreement, by and between the Company and FUJIFILM Cellular Dynamics Inc., dated September 22, 2023 (Filed With SEC on November 9, 2023)
- Second Amendment to License Agreement (Reprogramming), by and between the Company and FUJIFILM Cellular Dynamics Inc., dated September 22, 2023 (Filed With SEC on November 9, 2023)
- Separation Agreement and Release by and between the Company and Hyam Levitsky, M.D., dated January 23, 2023 (Filed With SEC on May 11, 2023)
- Executive Employment Agreement, by and between the Company and Hyam Levitsky, M.D., dated April 15, 2023 (Filed With SEC on May 11, 2023)
- Separation Agreement, between Century Therapeutics, Inc. and Osvaldo Flores, Ph.D. executed on May 5, 2023 (Filed With SEC on May 5, 2023)
- Side Letter to Executive Employment Agreement, between Century Therapeutics, Inc. and Gregory Russotti, Ph.D. dated as of April 12, 2023 (Filed With SEC on April 17, 2023)
- Amendment No. 4 to Master Collaboration Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated July 29, 2022 (Filed With SEC on November 10, 2022)
- Amendment No. 1 to Loan and Security Agreement, by and between Century Therapeutics, Inc. and Hercules Capital, Inc., dated May 13, 2022 (Filed With SEC on August 11, 2022)
- Research Collaboration and License Agreement, by and between Century Therapeutics, Inc. and Bristol-Myers Squibb Company, dated January 7, 2022 (Filed With SEC on March 17, 2022)
- Letter Agreement by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated January 7, 2022 (Filed With SEC on March 17, 2022)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 17, 2022)
- Securities Purchase Agreement, by and between Century Therapeutics, Inc. and Bristol-Myers Squibb Company, dated January 7, 2022 (Filed With SEC on January 10, 2022)
- License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on June 15, 2021)
- License Agreement (Differentiation), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on June 15, 2021)
- Executive Employment Agreement, by and between the Registrant and Luis Borges, Ph.D., datedMay 26, 2021 (Filed With SEC on June 14, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 14, 2021)
- Specimen Common Stock Certificate of Registrant (Filed With SEC on June 14, 2021)
- 2021 Equity Incentive Plan (Filed With SEC on June 14, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on June 14, 2021)
- Executive Employment Agreement, by and between the Registrant and Adrienne Farid, Ph.D., dated May 26, 2021 (Filed With SEC on June 14, 2021)
- Executive Employment Agreement, by and between the Registrant and Gregory Russotti, Ph.D., dated (Filed With SEC on June 14, 2021)
- Executive Employment Agreement, by and between the Registrant and Gregory Russotti, Ph.D., dated (Filed With SEC on May 28, 2021)
- Offer Letter, by and between the Registrant and Alessandro Riva, M.D., dated May 19, 2021 (Filed With SEC on May 28, 2021)
- Offer Letter, by and between the Registrant and Kimberly Blackwell, M.D., dated May 19, 2021 (Filed With SEC on May 28, 2021)
- Offer Letter, by and between the Registrant and Cynthia Butitta, dated February 25, 2021 (Filed With SEC on May 28, 2021)
- Offer Letter, by and between the Registrant and Joseph Jimenez, dated February 16, 2021 (Filed With SEC on May 28, 2021)
- Amendment No. 5 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
- Amendment No. 1 to Master Collaboration Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated July 17, 2020 (Filed With SEC on May 28, 2021)
- Master Collaboration Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated October 21, 2019 (Filed With SEC on May 28, 2021)
- Amended and Restated Option Agreement, by and between Century Therapeutics, Inc. and Bayer HealthCare LLC, dated February 25, 2021 (Filed With SEC on May 28, 2021)
- Form of Restricted Stock Unit Grant Notice and Award Agreement, under the 2021 Plan (Filed With SEC on May 28, 2021)
- Form of Stock Option Grant Notice and Award Agreement, under the 2021 Plan (Filed With SEC on May 28, 2021)
- Form of Incentive Stock Option Agreement, under the 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
- Form of Non-Qualified Stock Option Agreement, under the 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
- Form of Restricted Stock Award Agreement, under the 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
- Amendment No. 2 to Master Collaboration Agreement by and between Century Therapeutics, Inc. and (Filed With SEC on May 28, 2021)
- Amendment No. 4 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
- Amendment No. 3 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
- Amendment No. 2 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
- Amendment No. 1 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
- 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
- Form of Indemnification Agreement by and between the Registrant and its individual directors and officers (Filed With SEC on May 28, 2021)
- Warrant to Purchase Units of Century Therapeutics, LLC, in favor of Hercules Technology Management Co II, Inc., dated September 14, 2020 (Filed With SEC on May 28, 2021)
- Loan and Security Agreement, by and between Century Therapeutics, Inc. and Hercules Capital, Inc (Filed With SEC on May 28, 2021)
- Executive Employment Agreement, by and between the Registrant and Adrienne Farid, Ph.D., dated May 26, 2021 (Filed With SEC on May 28, 2021)
- Executive Employment Agreement, by and between the Registrant and Luis Borges, Ph.D., datedMay 26, 2021 (Filed With SEC on May 28, 2021)
- Executive Employment Agreement, by and between the Registrant and Hyam Levitsky, M.D., dated May 26, 2021 (Filed With SEC on May 28, 2021)
- Executive Employment Agreement, by and between the Registrant and Michael Diem, M.D., dated May 26, 2021 (Filed With SEC on May 28, 2021)
- Executive Employment Agreement, by and between the Registrant and Osvaldo Flores, Ph.D., dated May 26, 2021 (Filed With SEC on May 28, 2021)
- License Agreement, by and between Inscripta, Inc. and Century Therapeutics, Inc., dated January 1, 2019 (Filed With SEC on May 28, 2021)
- License Agreement, by and among the Governing Council of the University of Toronto, the McMaster University and Empirica Therapeutics, dated January 22, 2019 (Filed With SEC on May 28, 2021)
- Sublicense Agreement, by and between iCELL Inc. and Century Therapeutics, Inc., dated March 20, 2020 (Filed With SEC on May 28, 2021)
- Investors Rights Agreement, by and among the Registrant and each of the investors listed on Schedule A thereto, dated February 25, 2021 (Filed With SEC on May 28, 2021)
- Manufacturing and Supply Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated March 23, 2021 (Filed With SEC on May 28, 2021)
- Amendment No. 1 to License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated March 23, 2021 (Filed With SEC on May 28, 2021)
- License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on May 28, 2021)
- Amendment No. 1 to License Agreement (Differentiation), by and between Century Therapeutics, Inc (Filed With SEC on May 28, 2021)
- License Agreement (Differentiation), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on May 28, 2021)
- Letter Agreement, by and among Century Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc. and Wisconsin Alumni Research Foundation, dated July 2, 2019 (Filed With SEC on May 28, 2021)
- Amendment No. 3 to Master Collaboration Agreement by and between Century Therapeutics, Inc. and (Filed With SEC on May 28, 2021)